Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 899376 | ISIN: US5147661046 | Ticker-Symbol: LDE
Frankfurt
21.11.24
08:03 Uhr
6,950 Euro
+0,400
+6,11 %
1-Jahres-Chart
LIFECORE BIOMEDICAL INC Chart 1 Jahr
5-Tage-Chart
LIFECORE BIOMEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
7,2007,60015:38
7,3507,70015:38

Aktuelle News zur LIFECORE BIOMEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12:56LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report-
FrHere's Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR)2
08.11.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report-
07.11.Lifecore Biomedical, Inc.: Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 20241
04.11.Lifecore Biomedical Makes Leadership Appointments1
04.11.Lifecore Biomedical, Inc.: Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations1
LIFECORE BIOMEDICAL Aktie jetzt für 0€ handeln
11.10.Lifecore Biomedical GAAP EPS of -$0.53, revenue of $24.7M1
10.10.LIFECORE BIOMEDICAL, INC. \DE\ - S-8, Securities to be offered to employees in employee benefit plans2
10.10.LIFECORE BIOMEDICAL, INC. \DE\ - S-1, General form for registration of securities2
08.10.Research Analysts Issue Forecasts for Lifecore Biomedical, Inc.'s Q1 2026 Earnings (NASDAQ:LFCR)5
07.10.Earnings call: Lifecore Biomedical reports fiscal Q1 2025 results2
04.10.Lifecore Raises Millions in Common Stock-
04.10.LIFECORE BIOMEDICAL, INC. \DE\ - 10-Q, Quarterly Report1
04.10.Lifecore Biomedical, Inc.: Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update104-- Recorded Revenues of $24.7 Million for Q1 Fiscal 2025 -- -- Signed Multiple New Business Agreements with New and Existing Customers -- -- More than Doubled Capacity with Installation of 5-Head...
► Artikel lesen
04.10.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report1
04.10.Lifecore Biomedical raises $24.3M through private placement2
04.10.Lifecore Biomedical, Inc.: Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock1
03.10.Lifecore Biomedical, Inc.: Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 20241
01.10.Lindy Biosciences, Lifecore Biomedical Enter Multi-Million Dollar Development Agreement2
01.10.Lifecore secures $5M deal with Lindy Biosciences for CDMO services1
Seite:  Weiter >>
66 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1